Announced Fri, 24 Jul · 13:19 IST
32nd AGM held via video conferencing; annual accounts adopted with 100% approval
Board & Shareholder Meetings View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.9%1-day move
₹9.08
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.9-5.3————————
Up moveDown movePending
AI summary
Kobo Biotech held its 32nd AGM on July 24, 2026 via video conferencing. Only 41 public shareholders attended, representing 19,794 shares (0.08% of capital). The sole resolution to adopt annual accounts for FY ending March 2025 was passed with 100% approval (17,875 votes in favor, none against). The meeting was conducted by Resolution Professional Namrata Randeri, confirming the company remains under CIRP insolvency proceedings.
Likely market impact
Routine procedural filing. Company still under insolvency (CIRP). Extremely low shareholder turnout signals weak investor engagement.